Merck

Old-School Pharma/Biotech Dividend Paying Comparison

Old-School Pharma/Biotech Dividend Paying Comparison

Seeking Alpha

Bristol-Myers Squibb: The Untold Story Of Led Zeppelin

Bristol-Myers Squibb: The Untold Story Of Led Zeppelin

Seeking Alpha

The Dope On A Forest Labs Takeover

The Dope On A Forest Labs Takeover

Seeking Alpha

Analyst: Cancer Drugs Push Investors Into Pharma

Analyst: Cancer Drugs Push Investors Into Pharma

Barron's

Merck jumps on melanoma treatment results

Merck jumps on melanoma treatment results

Marketwatch

The Fast Paced World Of Advanced Cell Technology: An Interview With Chairman And CEO Gary Rabin

The Fast Paced World Of Advanced Cell Technology: An Interview With Chairman And CEO Gary Rabin

Seeking Alpha

Drugs Go From Hit to Dud in Two Years in Hepatitis Race

Drugs Go From Hit to Dud in Two Years in Hepatitis Race

Bloomberg

Bristol And Merck's Cancer Drugs Won ASCO. Five Slides Explain Why

Bristol And Merck's Cancer Drugs Won ASCO. Five Slides Explain Why.

TheStreet.com

Merck Rushes Forward In Race To Market Cell Death Cancer Drugs

Merck Rushes Forward In Race To Market Cell Death Cancer Drugs

Forbes

Merck's Anti-PD1 Melanoma Drugs Shrinks Tumors In Half of Patients

Merck's Anti-PD1 Melanoma Drugs Shrinks Tumors In Half of Patients

The Street